News
Bankers Reveal Top Biotech IPO Contenders; New Filer Ironwood Among Them BNET Pharma
View ArticleNews
No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business Seeking Alpha
View ArticleNews
Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting Sun Herald, MS
View ArticleThe top 10 biotech deal terminations of 2011
The top 10 biotech deal terminations of 2011 Fierce Biotech
View ArticlePfizer On The Move: A Rise In Dividend, Precious Approvals Gained
Pfizer On The Move: A Rise In Dividend, Precious Approvals Gained Seeking Alpha
View ArticleThe Best- And Worst-Performing Biotech Stocks, June 28 to July 5
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5 Forbes
View ArticleA Chart You Should See: Biotech IPO Class of 2013 Is Lagging
A Chart You Should See: Biotech IPO Class of 2013 Is Lagging TheStreet.com
View Article3 Lessons From the Biggest Biotech Event of 2014
3 Lessons From the Biggest Biotech Event of 2014 Motley Fool
View ArticleHere's Why Big Pharma is Rooting for Portola
Here's Why Big Pharma is Rooting for Portola Motley Fool
View ArticleToday’s Top Biotech Stories: Horizon Pharma, Prothena, and Portola...
Today’s Top Biotech Stories: Horizon Pharma, Prothena, and Portola Pharmaceuticals Motley Fool
View Article3 Stocks That Escaped Biotech's March Madness
3 Stocks That Escaped Biotech's March Madness Motley Fool
View ArticlePortola Pharmaceuticals begins enrollment in Phase 3 study for...
Portola Pharmaceuticals begins enrollment in Phase 3 study for Xarelto/andexanet alfa combo The Fly on the Wall
View ArticlePortola: A Small Biotech Stock That Could Double - And Then Double Again
Portola: A Small Biotech Stock That Could Double - And Then Double Again Seeking Alpha
View Article
